• OPEN AN ACCOUNT
Indian Indices
Nifty
25,355.25 -120.85
(-0.47%)
Sensex
83,190.28 -345.80
( -0.41%)
Bank Nifty
56,956.00 -257.55
( -0.45%)
Nifty IT
38,376.65 -304.20
( -0.79%)
Global Indices
Nasdaq
44,477.29 215.52
(0.49%)
Dow Jones
6,283.97 37.45
(0.60%)
Hang Seng
39,601.95 -219.33
(-0.55%)
Nikkei 225
8,975.66 108.64
(1.23%)
Forex
USD-INR
85.73 -0.06
(-0.07%)
EUR-INR
100.55 -0.15
(-0.15%)
GBP-INR
116.58 -0.23
(-0.19%)
JPY-INR
0.59 0.00
(-0.73%)

EQUITY - MARKET SCREENER

Industry :  
BSE Code
ISIN Demat
Book Value()
NSE Symbol
P/E(TTM)
Mar.Cap( Cr.)
EPS(TTM)
Face Value()
Div & Yield %
 

moil ltd
Sandu Pharmaceuticals consolidated net profit declines 44.07% in the March 2025 quarter
May 29,2025
Net profit of Sandu Pharmaceuticals declined 44.07% to Rs 0.33 crore in the quarter ended March 2025 as against Rs 0.59 crore during the previous quarter ended March 2024. Sales declined 9.81% to Rs 14.07 crore in the quarter ended March 2025 as against Rs 15.60 crore during the previous quarter ended March 2024.

For the full year,net profit rose 6.16% to Rs 1.55 crore in the year ended March 2025 as against Rs 1.46 crore during the previous year ended March 2024. Sales declined 0.13% to Rs 67.19 crore in the year ended March 2025 as against Rs 67.28 crore during the previous year ended March 2024.

ParticularsQuarter EndedYear Ended
Mar. 2025Mar. 2024% Var.Mar. 2025Mar. 2024% Var.
Sales14.0715.60 -10 67.1967.28 0
OPM %3.203.85 -4.113.42 -
PBDT0.490.91 -46 2.832.66 6
PBT0.340.72 -53 2.162.07 4
NP0.330.59 -44 1.551.46 6